Lobomycosis: a therapeutic challenge

An Bras Dermatol. 2018 Mar;93(2):279-281. doi: 10.1590/abd1806-4841.20187044.

Abstract

Lobomycosis or lacaziosis is a chronic granulomatous fungal infection caused by Lacazia loboi. Most cases are restricted to tropical regions. Transmission is believed to occur through traumatic inoculation in the skin, mainly in exposed areas. It is characterized by keloid-like nodules. There are only a few hundred cases reported. The differential diagnoses include many skin conditions, and treatment is difficult. The reported case, initially diagnosed as keloid, proved to be refractory to surgical treatment alone. It was subsequently approached with extensive surgery, cryotherapy every three months and a combination of itraconazole and clofazimine for two years. No signs of clinical and histopathological activity were detected during follow-up.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Biopsy
  • Clofazimine / therapeutic use
  • Cryotherapy / methods
  • Diagnosis, Differential
  • Ear Diseases / diagnosis
  • Ear Diseases / pathology*
  • Ear Diseases / therapy*
  • Humans
  • Itraconazole / therapeutic use
  • Keloid / diagnosis
  • Keloid / pathology*
  • Lobomycosis / diagnosis
  • Lobomycosis / pathology*
  • Lobomycosis / therapy*
  • Male
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Itraconazole
  • Clofazimine